Examining Gender as a Sociocultural Variable Shaping Health Outcomes of Cancer Caregiving
检查性别作为影响癌症护理健康结果的社会文化变量
基本信息
- 批准号:10770121
- 负责人:
- 金额:$ 16.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-19 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdministrative SupplementAppointmentBehaviorBeliefBudgetsCancer SurvivorCancer SurvivorshipCaregiversCaringCharacteristicsClinicalDataDedicationsDimensionsDiseaseDistressEarly DiagnosisEligibility DeterminationEnrollmentEvolutionFaceFamilyFamily memberFatigueFeasibility StudiesFriendsFundingGenderGender RelationsGoalsHairHealthHealth PromotionHealthcareHeterogeneityHospitalizationHydrocortisoneIndividualInstitutional Review BoardsInterventionInterviewKnowledgeLinkMalignant NeoplasmsMapsMedicalMentorsMethodsMonitorMorbidity - disease rateOutcomePainParentsParticipantPathway interactionsPatient Self-ReportPatientsPersonal SatisfactionPhysical FunctionPhysically ChallengedPopulationProtocols documentationProviderPsychologistRandomizedRelaxation TherapyResearchResearch PersonnelResearch SupportResourcesRiskRoleScienceSelf CareShapesStrategic PlanningStressSupport GroupsSurveysSurvivorsSymptomsTestingTrainingUnited States National Institutes of HealthVisitWomanWomen&aposs HealthWorkacceptability and feasibilitybiobehaviorcancer carecancer therapycare giving burdencare recipientscareer developmentcaregivingcaregiving researchdisorder preventionemotional distressexperiencefollow-upgender differencehealth care service utilizationhealth differencehealth equity promotionindexingintervention effectintervention programintimate behaviormanmortalitynext generationnovelparent grantpilot trialpoor health outcomeprimary outcomeprogramspromote resiliencerandomized trialrecruitresilienceresponsesatisfactionscreeningsecondary analysissexsocial culturestress managementstress resiliencestressorsurvivorshiptraittreatment as usualtreatment effecttreatment group
项目摘要
PROJECT SUMMARY/ABSTRACT
With advances in early detection and novel, targeted cancer treatments, a growing number of individuals
provide support for cancer survivors who have completed curative intent therapy (“curvivors”) as well as for
those who live for many years with metastatic disease (“metavivors”). Cancer caregiving relationships for
curvivors and metavivors alike are associated with high stress, particularly as individuals transition to post-
initial treatment survivorship and experience decreased contact with medical providers, continued need for
medical symptom monitoring, and evolution in relationship dynamics between caregiver and care recipient. As
such, caregivers (partners, family members, close friends) may struggle with unmet needs for their own well-
being and healthcare utilization (e.g., attendance at follow-up visits, routine healthcare screenings) while
supporting the survivor they care for. Though caregiving roles are disproportionately held by women, little is
known about possible gender differences in the health impact of cancer caregiving stress during the transition
to post-initial treatment survivorship. No existing interventions provide concurrent but separate support for
cancer survivors and caregivers at this critical transition point; as such, the parent R21 (“Building Resiliency
Among Caregivers of Curvivors and Metavivors: A Pilot Randomized Trial,” R21 CA273785-01) is highly novel
in its aim to evaluate the feasibility, acceptability, and preliminary efficacy of the Stress Management and
Resiliency Training-Relaxation Resiliency Response Program (SMART-3RP) as delivered concurrently to
separate groups of cancer caregivers and survivors. Building upon the aims of the parent grant, this
Administrative Supplement (in response to NOT-OD-22-030) will explicate key indices of feasibility and
acceptability by participant gender. Leveraging quantitative self-report and biobehavioral (i.e., hair cortisol)
data from 48 cancer caregiver-survivor dyads (N = 96), we will also analyze gender differences in baseline
characteristics mapping onto gender as a sociocultural variable (i.e., gender norms, gender-related traits, and
gender relations), as well as gender differences in preliminary efficacy of the SMART-3RP for caregivers’ and
survivors’ resiliency (primary) and healthcare utilization (secondary). To enrich interpretation of quantitative
analyses, we will add 3 questions to the planned qualitative exit interviews, regarding of sociocultural aspects
of gender in cancer caregiving. This Administrative Supplement will provide timely support for the research
team to meaningfully generate empirical mixed-methods data regarding gender differences in intervention
feasibility, acceptability, and preliminary efficacy and promote health equity for women in the growing
landscape of cancer caregiving research. Further, this work will provide a critical opportunity for MPIs Park and
El-Jawahri to support Dr. Lucy Finkelstein-Fox, a promising junior investigator mentored by Drs. Park and El-
Jawahri whose research program is dedicated to women’s health and intimacy in cancer survivorship.
项目总结/摘要
随着早期检测和新型靶向癌症治疗的进展,越来越多的人
为已经完成治愈性治疗的癌症幸存者(“curvivors”)提供支持,
那些患有转移性疾病多年的人(“转移存活者”)。巨蟹座的人际关系
曲线生存者和后生存者都与高压力有关,特别是当个体过渡到后
初始治疗存活率和经验减少与医疗提供者的接触,
医学症状监测以及护理者和护理接受者之间的关系动态的演变。作为
这样,照顾者(伴侣、家庭成员、亲密朋友)可能会为自己的健康而努力满足未满足的需求,
存在和保健利用(例如,参加随访访视、常规医疗筛查),
支持他们所关心的幸存者尽管女性在这方面的比例很高,
了解在过渡期间癌症对健康的影响可能存在性别差异
到初始治疗后的存活率。现有的干预措施没有同时提供单独的支持,
癌症幸存者和照顾者在这个关键的过渡点;因此,父母R21(“建设弹性
在Curvivors和Metavivors的护理者中:一项初步随机试验,”R21 CA 273785 -01)是高度新颖的
目的是评估压力管理的可行性、可接受性和初步疗效,
弹性训练-放松弹性反应计划(SMART-3RP),同时提供给
不同的癌症护理人员和幸存者群体。根据父母补助金的目标,
行政补充(响应NOT-OD-22-030)将阐明可行性的关键指标,
参与者性别的可接受性。利用定量自我报告和生物行为(即,毛发皮质醇)
数据来自48个癌症护理者-幸存者二元组(N = 96),我们还将分析基线的性别差异
作为社会文化变量映射到性别上的特征(即,性别规范,性别相关特征,
性别关系),以及SMART-3RP对照顾者的初步疗效的性别差异,
幸存者的弹性(主要)和医疗保健利用(次要)。为了丰富定量解释,
分析,我们将在计划的定性离职面谈中增加3个问题,涉及社会文化方面
癌症护理中的性别问题。本行政补充文件将为研究提供及时的支持
小组就干预措施中的性别差异有意义地生成经验性混合方法数据
可行性、可接受性和初步疗效,促进日益增长的妇女健康公平
癌症研究的前景。此外,这项工作将为MPI公园提供一个关键的机会,
El-Jawahri支持Lucy Finkelstein-Fox博士,一位由Park博士和El博士指导的有前途的初级研究员,
她的研究项目致力于妇女的健康和癌症生存的亲密关系。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Areej El-Jawahri其他文献
Areej El-Jawahri的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Areej El-Jawahri', 18)}}的其他基金
Building Resiliency Among Caregivers of Curvivors and Metavivors: A Pilot randomized Trial
建立幸存者和元幸存者的照顾者的复原力:一项随机试点试验
- 批准号:
10509455 - 财政年份:2022
- 资助金额:
$ 16.56万 - 项目类别:
Randomized Trial of a Home-Advance Care Planning Video Intervention for Patients with Life-limiting Illness
针对生命有限疾病患者的家庭预先护理计划视频干预的随机试验
- 批准号:
10028263 - 财政年份:2020
- 资助金额:
$ 16.56万 - 项目类别:
Randomized Trial of a Home-Advance Care Planning Video Intervention for Patients with Life-limiting Illness
针对生命有限疾病患者的家庭预先护理计划视频干预的随机试验
- 批准号:
10636846 - 财政年份:2020
- 资助金额:
$ 16.56万 - 项目类别:
Randomized Trial of a Home-Advance Care Planning Video Intervention for Patients with Life-limiting Illness
针对生命有限疾病患者的家庭预先护理计划视频干预的随机试验
- 批准号:
10252907 - 财政年份:2020
- 资助金额:
$ 16.56万 - 项目类别:
Randomized Trial of a Home-Advance Care Planning Video Intervention for Patients with Life-limiting Illness
针对生命有限疾病患者的家庭预先护理计划视频干预的随机试验
- 批准号:
10412118 - 财政年份:2020
- 资助金额:
$ 16.56万 - 项目类别:
Multimodal Mobile Intervention Application (app) to Address Symptoms in Hematopoietic Stem Cell Transplant Survivors
用于解决造血干细胞移植幸存者症状的多模式移动干预应用程序 (app)
- 批准号:
10000145 - 财政年份:2019
- 资助金额:
$ 16.56万 - 项目类别:
Randomized Trial of Inpatient Palliative Care for Patients with Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplantation
接受造血干细胞移植的血液恶性肿瘤患者住院姑息治疗的随机试验
- 批准号:
9980805 - 财政年份:2018
- 资助金额:
$ 16.56万 - 项目类别:
Randomized Trial of Inpatient Palliative Care for Patients with Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplantation
接受造血干细胞移植的血液恶性肿瘤患者住院姑息治疗的随机试验
- 批准号:
10456762 - 财政年份:2018
- 资助金额:
$ 16.56万 - 项目类别:
Randomized Trial of Inpatient Palliative Care for Patients with Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplantation
接受造血干细胞移植的血液恶性肿瘤患者住院姑息治疗的随机试验
- 批准号:
10222595 - 财政年份:2018
- 资助金额:
$ 16.56万 - 项目类别:
Randomized Trial of Inpatient Palliative Care for Patients with Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplantation
接受造血干细胞移植的血液恶性肿瘤患者住院姑息治疗的随机试验
- 批准号:
9761504 - 财政年份:2018
- 资助金额:
$ 16.56万 - 项目类别:
相似海外基金
Proton-secreting epithelial cells as key modulators of epididymal mucosal immunity - Administrative Supplement
质子分泌上皮细胞作为附睾粘膜免疫的关键调节剂 - 行政补充
- 批准号:
10833895 - 财政年份:2023
- 资助金额:
$ 16.56万 - 项目类别:
A Longitudinal Qualitative Study of Fentanyl-Stimulant Polysubstance Use Among People Experiencing Homelessness (Administrative supplement)
无家可归者使用芬太尼兴奋剂多物质的纵向定性研究(行政补充)
- 批准号:
10841820 - 财政年份:2023
- 资助金额:
$ 16.56万 - 项目类别:
StrokeNet Administrative Supplement for the Funding Extension
StrokeNet 资助延期行政补充文件
- 批准号:
10850135 - 财政年份:2023
- 资助金额:
$ 16.56万 - 项目类别:
2023 NINDS Landis Mentorship Award - Administrative Supplement to NS121106 Control of Axon Initial Segment in Epilepsy
2023 年 NINDS 兰迪斯指导奖 - NS121106 癫痫轴突初始段控制的行政补充
- 批准号:
10896844 - 财政年份:2023
- 资助金额:
$ 16.56万 - 项目类别:
Biomarkers of Disease in Alcoholic Hepatitis Administrative Supplement
酒精性肝炎行政补充剂中疾病的生物标志物
- 批准号:
10840220 - 财政年份:2023
- 资助金额:
$ 16.56万 - 项目类别:
Administrative Supplement: Life-Space and Activity Digital Markers for Detection of Cognitive Decline in Community-Dwelling Older Adults: The RAMS Study
行政补充:用于检测社区老年人认知衰退的生活空间和活动数字标记:RAMS 研究
- 批准号:
10844667 - 财政年份:2023
- 资助金额:
$ 16.56万 - 项目类别:
Administrative Supplement: Improving Inference of Genetic Architecture and Selection with African Genomes
行政补充:利用非洲基因组改进遗传结构的推断和选择
- 批准号:
10891050 - 财政年份:2023
- 资助金额:
$ 16.56万 - 项目类别:
Power-Up Study Administrative Supplement to Promote Diversity
促进多元化的 Power-Up 研究行政补充
- 批准号:
10711717 - 财政年份:2023
- 资助金额:
$ 16.56万 - 项目类别:
Administrative Supplement for Peer-Delivered and Technology-Assisted Integrated Illness Management and Recovery
同行交付和技术辅助的综合疾病管理和康复的行政补充
- 批准号:
10811292 - 财政年份:2023
- 资助金额:
$ 16.56万 - 项目类别:
Sedentary behavior, physical activity, and 24-hour behavior in pregnancy and offspring health: the Pregnancy 24/7 Offspring Study Administrative Supplement
久坐行为、体力活动和 24 小时行为对怀孕和后代健康的影响:怀孕 24/7 后代研究行政补充
- 批准号:
10893074 - 财政年份:2023
- 资助金额:
$ 16.56万 - 项目类别: